Hannover Medical School, Institute of Molecular and Translational Therapeutic Strategies, Carl-Neuberg-Strasse 1, Hannover, Germany.
Circ Res. 2011 Jul 22;109(3):334-47. doi: 10.1161/CIRCRESAHA.110.228676.
MicroRNAs (miRNAs) are important regulators of gene expression and fundamentally impact on cardiovascular function in health and disease. A tight control of miRNA expression is crucial for the maintenance of tissue homeostasis. However, a comprehensive understanding of the various levels of miRNA regulation is in its infancy. We here summarize the current knowledge about regulation of cardiovascular miRNAs at the transcriptional level by transcription factors, during processing by the Drosha and Dicer complexes and the importance of miRNA modification, editing, and decay mechanisms. As an example, miRNA regulation in diabetic and hypoxic cardiovascular disease conditions is discussed. Better knowledge about regulatory mechanisms of miRNAs in cardiovascular disease will probably lead to improved and novel miRNA-based therapeutic therapies.
微小 RNA(miRNAs)是基因表达的重要调控因子,对心血管功能在健康和疾病中的影响具有基础性作用。miRNA 表达的严格控制对组织内稳态的维持至关重要。然而,对于 miRNA 调控的各个层面的全面理解还处于起步阶段。在这里,我们总结了转录因子在转录水平上对心血管 miRNA 进行调控的最新知识,包括 Drosha 和 Dicer 复合物的加工以及 miRNA 修饰、编辑和降解机制的重要性。我们还以糖尿病和低氧性心血管疾病为例,讨论了 miRNA 的调节。更好地了解心血管疾病中 miRNA 的调控机制,可能会带来改良的、基于 miRNA 的新型治疗方法。